Vivimed Labs Ltd - VIVIMED LABS. Share Price

Sector: Pharmaceuticals | ISIN: INE526G01021
₹ 9.80 (%) icon1 Dec, 2022, 3:41:38 PM
Open
₹ 9.75
Prev. Close
Turnover(lac)
₹ 0.00
Day's High
₹ 9.80
Day's Low
₹ 9.70
52 Wk High
₹ 7.65
52 Wk Low
₹ 4.85
Book Value
₹ 5.33
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 81.26
P/E
0.00
EPS
0.00
Div. Yield
0.00

Vivimed Labs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 12/1/2022 3:41:38 PM

    ₹ 9.8
  • Open
  • ₹ 9.75
  • Prev. Close
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 9.8
  • Day's Low
  • ₹ 9.7
  • 52 Week's High
  • ₹ 7.65
  • 52 Week's Low
  • ₹ 4.85
  • Book Value
  • ₹ 5.33
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 81.26
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Vivimed Labs Ltd Corporate Actions

31 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

28 Oct , 2023

12:00 AM

28 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Oct , 2023

12:00 AM

AGM

Announcement date: 18 Oct , 2023

View Details

18 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2023

12:00 AM

18 May , 2023

12:00 AM

18 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 Feb , 2023

12:00 AM

AGM

Announcement date: 13 Feb , 2023

View Details

15 Feb , 2023

12:00 AM

BookCloser

View Details

18 Oct , 2023

12:00 AM

BookCloser

View Details

Vivimed Labs Ltd News and Update

Image not found
  • 1 day ago |
  • 12:18 AM

The complaint alleges Dr Reddy's "improperly restrained competition" and maintained a monopoly for the cancer drug Revlimid.

Image not found
  • IIFL News Service |
  • 27 February, 2024 |
  • 12:13 AM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Vivimed Labs Ltd SHAREHOLDING SNAPSHOT
02 March , 2024 | 07:41 PM

PROMOTER - TOTAL20.94%

Indian: 20.94%

Foreign: 0%

NON-PROMOTER - TOTAL 79.06%

Institutions: 1.76%

Non-Institutions: 77.30%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Vivimed Labs Ltd FINANCIALS

Vivimed Labs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Vivimed Labs Ltd

  • Santosh Varalwar
  • Managing Director & CEO
  • Subhash Varalwar
  • Whole-time Director
  • V Manohar Rao
  • Whole-time Director
  • M Bhagavantha Rao
  • Independent Director
  • Sandeep Varalwar
  • Whole-time Director
  • S Raghunandan
  • Whole Time Director & CFO
  • V Peesapati
  • Independent Director
  • Yugandhar Kopparthi
  • Company Secretary
  • Aparna Bidarkar
  • Additional Director

Summary

Vivimed Labs Ltd is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, APIs and Formulations. The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing. The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc. The company operates in two different industry segments, namely Specialty Chemicals and Pharma Manufacturing. The specialty chemicals segment manufactures a range of products active ingredients for home and personal care and personal hygiene products. Pharmaceutical segment is engaged in contract manufacturing and job works. The companys portfolio has a range of specialty chemicals (active ingredients) supplied to manufacturers of beauty care products like hair care, skin care, sun care and oral care products, industrial care products, such as anti-microbial, anti-fouling agents and biocides and health care products like pharmaceutical finished drug forms for cancer, tuberculosis.The companys manufacturing capacities are broadly divided into: cGMP manufacturing facility located at Bidar in Karnataka State of India- capacity 250 kl per day. A second cGMP plant, located at Bonthapalli, Hyderabad, India- capacity 400 kl per day. Three Pharmaceutical Finished Dose Plants: at Jeedimetla, Hyderabad, Kashipur, Uttarakhand, Haridwar, Uttarakhand: with... Read More


Reports by Vivimed Labs Ltd


Reports by Vivimed Labs Ltd

Company FAQ

No Record Found